Literature DB >> 18075794

Genetics of clinical expression in SLE.

Bahram Namjou1, Jeff Kilpatrick, John B Harley.   

Abstract

Systemic lupus erythematosus (SLE) is the prototype of complex autoimmune diseases and is characterized by extreme breakdown of self-tolerance which results in a wide range of immunologic abnormalities and immune complex formation. Genetic, hormonal and environmental factors are known to contribute to the expression of the disease. SLE is very heterogeneous in clinical manifestations and different autoantibodies may predict different set of clinical outcome, however, despite considerable accumulated knowledge, the detailed pathogenesis of SLE still remains unknown. In genetic studies, recent findings in gene expression analyses strongly support the direct role of cytokines and interferons in various immune dysregulations described in SLE. By recent advances in high-throughput SNP genotyping, the association studies of this complex disease have become more practical and for the first time new genetic association results can be confirmed in different population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18075794     DOI: 10.1080/08916930701510962

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  14 in total

1.  Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) mediates p38 mitogen-activated protein kinase activation and signal transduction in peripheral blood mononuclear cells from patients with lupus nephritis.

Authors:  Liu Zhi-Chun; Zhou Qiao-Ling; Liu Zhi-Qin; Li Xiao-Zhao; Zuo Xiao-xia; Tang Rong
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

Review 2.  Macrophages and immunologic inflammation of the kidney.

Authors:  Jeremy S Duffield
Journal:  Semin Nephrol       Date:  2010-05       Impact factor: 5.299

3.  B Cell-Intrinsic SHP1 Expression Promotes the Gammaherpesvirus-Driven Germinal Center Response and the Establishment of Chronic Infection.

Authors:  K E Johnson; P T Lange; C N Jondle; P J Volberding; U M Lorenz; W Cui; B N Dittel; V L Tarakanova
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

Review 4.  Computation as the mechanistic bridge between precision medicine and systems therapeutics.

Authors:  J Hansen; R Iyengar
Journal:  Clin Pharmacol Ther       Date:  2012-12-05       Impact factor: 6.875

Review 5.  Monogenic systemic lupus erythematosus: insights in pathophysiology.

Authors:  Ezgi Deniz Batu
Journal:  Rheumatol Int       Date:  2018-05-15       Impact factor: 2.631

6.  Complete complement deficiency in a large cohort of familial systemic lupus erythematosus.

Authors:  R Aggarwal; A L Sestak; A D'Souza; A D'Sousa; S P Dillon; B Namjou; R H Scofield
Journal:  Lupus       Date:  2009-11-12       Impact factor: 2.911

Review 7.  Epstein-Barr virus and systemic lupus erythematosus.

Authors:  Anette Holck Draborg; Karen Duus; Gunnar Houen
Journal:  Clin Dev Immunol       Date:  2012-07-03

8.  Monogenic forms of systemic lupus erythematosus: new insights into SLE pathogenesis.

Authors:  Alexandre Belot; Rolando Cimaz
Journal:  Pediatr Rheumatol Online J       Date:  2012-08-10       Impact factor: 3.054

9.  Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.

Authors:  Anette H Draborg; Magnus C Lydolph; Marie Westergaard; Severin Olesen Larsen; Christoffer T Nielsen; Karen Duus; Søren Jacobsen; Gunnar Houen
Journal:  PLoS One       Date:  2015-09-24       Impact factor: 3.240

Review 10.  Epstein-Barr virus in systemic autoimmune diseases.

Authors:  Anette Holck Draborg; Karen Duus; Gunnar Houen
Journal:  Clin Dev Immunol       Date:  2013-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.